S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
NYSE:BAX

Baxter International Stock Forecast, Price & News

$85.96
-0.32 (-0.37%)
(As of 01/24/2022 04:00 PM ET)
Add
Compare
Today's Range
$84.03
$86.05
50-Day Range
$74.57
$88.00
52-Week Range
$73.12
$88.91
Volume
3.51 million shs
Average Volume
2.41 million shs
Market Capitalization
$43.04 billion
P/E Ratio
35.97
Dividend Yield
1.30%
Beta
0.65
30 days | 90 days | 365 days | Advanced Chart
Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.


Baxter International logo

About Baxter International

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Headlines

Two Health Care Stocks With Double-Digit Upside
January 5, 2022 |  marketbeat.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
50,000
Year Founded
1931

Sales & Book Value

Annual Sales
$11.67 billion
Cash Flow
$4.83 per share
Book Value
$17.28 per share

Profitability

Net Income
$1.10 billion
Pretax Margin
11.28%

Debt

Price-To-Earnings

Miscellaneous

Free Float
499,742,000
Market Cap
$43.04 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/27/2021
Ex-Dividend for 1/3 Dividend
12/02/2021
Dividend Payable
1/03/2022
Today
1/25/2022
Next Earnings (Confirmed)
2/17/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.99 out of 5 stars

Medical Sector

18th out of 1,415 stocks

Surgical & Medical Instruments Industry

3rd out of 130 stocks

Analyst Opinion: 3.4Community Rank: 4.7Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












Baxter International (NYSE:BAX) Frequently Asked Questions

Is Baxter International a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view top-rated stocks.

How has Baxter International's stock been impacted by Coronavirus?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 10.2% and is now trading at $85.96.
View which stocks have been most impacted by COVID-19
.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Baxter International
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, February 17th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) issued its quarterly earnings data on Wednesday, October, 27th. The medical instruments supplier reported $1.02 EPS for the quarter, beating the Zacks' consensus estimate of $0.94 by $0.08. The medical instruments supplier earned $3.23 billion during the quarter, compared to the consensus estimate of $3.23 billion. Baxter International had a net margin of 9.75% and a trailing twelve-month return on equity of 19.94%. The company's revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.83 earnings per share.
View Baxter International's earnings history
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, November 16th. Shareholders of record on Friday, December 3rd will be given a dividend of $0.28 per share on Monday, January 3rd. This represents a $1.12 annualized dividend and a dividend yield of 1.30%. The ex-dividend date of this dividend is Thursday, December 2nd.
View Baxter International's dividend history
.

Is Baxter International a good dividend stock?

Baxter International pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.30%. Baxter International has been increasing its dividend for 6 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 46.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 26.48% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of $3.580-$3.620 for the period, compared to the Thomson Reuters consensus estimate of $3.520. The company issued revenue guidance of $12.49 billion-$12.61 billion, compared to the consensus revenue estimate of $12.61 billion.

What price target have analysts set for BAX?

13 brokers have issued 1-year price objectives for Baxter International's stock. Their forecasts range from $80.00 to $110.00. On average, they anticipate Baxter International's stock price to reach $95.30 in the next year. This suggests a possible upside of 10.9% from the stock's current price.
View analysts' price targets for Baxter International
or view top-rated stocks among Wall Street analysts.

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Joe Almeida, Chairman, President & Chief Executive Officer
  • Giuseppe Accogli, Chief Operating Officer & Executive Vice President
  • James K. Saccaro, Chief Financial Officer & Executive Vice President
  • Paulo Henrique Bolgar, Vice President-Research & Development
  • Sumant Ramachandra, Chief Science & Technology Officer, Senior VP

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), (HON), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different retail and institutional investors. Top institutional shareholders include New York State Teachers Retirement System (0.11%), Russell Investments Group Ltd. (0.06%), Huntington National Bank (0.05%), Gulf International Bank UK Ltd (0.02%), DNB Asset Management AS (0.02%) and Beese Fulmer Investment Management Inc. (0.01%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends for Baxter International
.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Huntington National Bank, Gulf International Bank UK Ltd, Ferguson Wellman Capital Management Inc., New York State Teachers Retirement System, Parallel Advisors LLC, Peoples Financial Services CORP., New Mexico Educational Retirement Board, and West Oak Capital LLC. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, and Andrew Frye.
View insider buying and selling activity for Baxter International
or view top insider-selling stocks.

Which institutional investors are buying Baxter International stock?

BAX stock was purchased by a variety of institutional investors in the last quarter, including Dixon Hubard Feinour & Brown Inc. VA, DNB Asset Management AS, Washington Capital Management Inc., Lindbrook Capital LLC, Trust Co. of Vermont, NuWave Investment Management LLC, Carroll Financial Associates Inc., and Rothschild Investment Corp IL.
View insider buying and selling activity for Baxter International
or or view top insider-buying stocks.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $85.96.

How much money does Baxter International make?

Baxter International has a market capitalization of $43.04 billion and generates $11.67 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $2.39 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 50,000 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

When was Baxter International founded?

Baxter International was founded in 1931.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

Where are Baxter International's headquarters?

Baxter International is headquartered at One Baxter Parkway DF2-1W, Deerfield IL, 60015.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at [email protected], or via fax at 224-948-1813.


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.